CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Increasing preference for minimally invasive surgeries
4.1.2. Rising prevalence of cancer and improved reimbursement scenario in the U.S.
4.1.3. Initiatives are undertaken by government and global health organisations
4.1.4. Emerging economies regarding biopsy devices
4.2. Market Restraints & Challenges
4.2.1. Risk of infections and product recalls
4.2.2. Under developed healthcare infrastructure and a dearth of resources in developing
economies.
CHAPTER 5 GLOBAL BIOPSY DEVICES MARKET – BY GUIDANCE TECHNIQUE
5.1. MRI-Guided Biopsy
5.2. Stereotactic-Guided Biopsy
5.3. Ultrasound-Guided Biopsy
5.4. Others
CHAPTER 6 GLOBAL BIOPSY DEVICES MARKET – BY PRODUCT
6.1. Procedure Trays
6.2. Localization Wires
6.3. Needle-Based Biopsy Instruments
6.3.1. Vacuum-Assisted Biopsy Devices
6.3.2. Core Biopsy Devices
6.3.3. Aspiration Biopsy Needles
6.4. Others
CHAPTER 7 GLOBAL BIOPSY DEVICES MARKET – BY APPLICATION
7.1. Prostate Biopsy
7.2. Colorectal Biopsy
7.3. Lung Biopsy
7.4. Breast Biopsy
7.5. Others
CHAPTER 8 GLOBAL BIOPSY DEVICES MARKET – BY END USER
8.1. Diagnostic and Imaging Centers
8.2. Academic and Research Institutes
8.3. Hospitals
8.4. Others
CHAPTER 9 GLOBAL BIOPSY DEVICES MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL BIOPSY DEVICES MARKET - COMPANY PROFILES
10.1. Argon Medical Devices, Inc.
10.2. B. Braun Melsungen AG
10.3. Cardinal Health, Inc.
10.4. Olympus Corporation
10.5. Boston Scientific Corporation
10.6. Fujifilm Holdings Corporation
10.7. Inrad, Inc.
10.8. Hologic, Inc.
10.9. Medtronic PLC
10.10. C. R. Bard, Inc.
10.11. Becton, Dickinson and Company
10.12. Cook Group Incorporated
10.13. Danaher Corporation
CHAPTER 11 GLOBAL BIOPSY DEVICES MARKET – COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
